Clinical Trial Record

Return to Clinical Trials

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Treatment


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
Triple


Arms and Interventions

Participant Group/ArmIntervention/Treatment
ACTIVE_COMPARATOR: Early oral feeding

TIME OF FEEDING. 48 hours after pancreatitis general management is started ( liquid diet)

DIETARY_SUPPLEMENT: TIME OF FEEDING

  • Liquid ( Re Feeding 8 h ) OR Enteral Feeding ( re feeding 48 h)
EXPERIMENTAL: Immediate oral feeding

TIME OF FEEDING: 8 hours of after pancreatitis general management is started (enteral formula)

DIETARY_SUPPLEMENT: TIME OF FEEDING

  • Liquid ( Re Feeding 8 h ) OR Enteral Feeding ( re feeding 48 h)
Primary Outcome MeasuresMeasure DescriptionTime Frame
Pancreatitis reactivation after oral FeedingResurgence of characteristically epigastric tansfictive pain, irradiated to the left, upper quadrant region after beginning the oral intake, systemic inflammatory response syndrome ( C reactive protein) or Significant leucocyte elevationMeasures at 24hours after the begining of the oral intake
Pancreatitis reactivation after oral FeedingResurgence of characteristically epigastric tansfictive pain, irradiated to the left, upper quadrant region after beginning the oral intake, systemic inflammatory response syndrome ( C reactive protein) or Significant leucocyte elevationMeasures at 48hours after the begining of the oral intake

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
15 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:
    Patients older than 15 years.

  • Patients with a diagnosis of mild acute pancreatitis biliary.
  • Patients who agree to enter the protocol.

  • Exclusion Criteria:

  • Patients managed at another institution.


  • Patients with a diagnosis of pancreatitis of non-biliary etiology.
  • Patients with heart disease or lung disease.
  • Patients with organic failure.
  • Patients with pregnancy.
  • Patients with cholangitis.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • STUDY_CHAIR: Juan F Hernandez, Postgraduate office at UASLP

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available